Live Breaking News & Updates on Vikas dandekar

Stay updated with breaking news from Vikas dandekar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

India Sees 400,000 New Cases in a Day: COVID-Crisis Updates


India Sees 400,000 New Cases in a Day: COVID-Crisis Updates
Intelligencer
3 hrs ago
Chas Danner
© Tauseef Mustafa/AFP via Getty Images
A COVID-19 patient rests inside a banquet hall temporarily converted into a coronavirus ward in New Delhi on Friday. Tauseef Mustafa/AFP via Getty Images
India continues to face the world’s most devastating wave of the coronavirus pandemic, an onslaught of infections and deaths that has overwhelmed the nation’s health-care system and prompted lockdowns across the country. Each day now brings a world record in new cases per day, with the nation reporting more than 400,000 on Saturday — the tenth straight day more than 300,000 cases have been confirmed. Though international aid continues to arrive, including from the U.S., well over 3,000 people are dying every day as well, and both that and the number of new infections are via the government’s official count — which is definitely much lower than the actual numbers of sick and dying, according to local journalists. Below is an ongoing look at the staggering crisis, including new developments and the likely consequences.

India , New-york , United-states , Mumbai , Maharashtra , New-delhi , Delhi , White-house , District-of-columbia , Brazil , China , South-africa

In Covid's grip, India gasps for air: 'If there is an apocalypse, this has to be one'


"I have placed 3 Quarks Daily at the head of my list of web bookmarks."

"3 Quarks Daily is a warm and often amusing home for intellectuals and other wags."

"3 Quarks Daily is terrific - many congratulations, and many thanks!"

"I'm a big admirer of 3 Quarks Daily!"

William Dalrymple, award winning historian and travel writer, as well as distinguished broadcaster, critic, art historian, foreign correspondent and founder and co-director of Asia's largest literary festival.
3 Quarks Daily is an essential stop for any serious reader on the Web."

Ken Roth, Executive Director of Human Rights Watch since 1993.
"The algorithms that curate your social-media timeline do so with indifference and programmed greed. The humans who curate 3QD do so with love and well-aged wisdom. Read 3QD instead! It’s so much better!"

Vikas-dandekar , Stat-news , விகாஸ்-தண்டேகர் , ஸ்ட்யாட்-செய்தி ,

Biden's economic plan leaves health policy fights behind


POLITICO
Get the POLITICO Pulse newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by Facebook
With Rachel Roubein, Alice Miranda Ollstein and David Lim
Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories.

China , New-york , United-states , Pennsylvania , India , Capitol-hill , District-of-columbia , White-house , America , American , Donald-trump , Francis-collins

molnupiravir Vaccine: MSD in talks with Medicines Patent Pool for additional licenses for molnupiravir

molnupiravir Vaccine: MSD in talks with Medicines Patent Pool for additional licenses for molnupiravir
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

India , Vikas-dandekar , Ridgeback-biotherapeutics , Rehan-khan , Managing-director , India-region , Medicines-patent-pool , இந்தியா , விகாஸ்-தண்டேகர் , ரேஹான்-காந் , நிர்வகித்தல்-இயக்குனர்

Natco Seeks emergency approval to launch Molnupiravir for Covid-19 in India

Molnupiravir was originally developed to treat influenza before US-based Merck initiated research to repurpose drug for use against SARS-CoV-2 virus.

Hyderabad , Andhra-pradesh , India , Vikas-dandekar , Rajiv-nannapaneni , Natco-pharma , Vice-chairman , Drug-controller-general , Subject-expert-committee , Intensive-care-unit , Emergency-use-authorization

Morning Brief: Fast and furious: Lowdown on the premium Covid treatment drug, Remdesivir

Morning Brief: Fast and furious: Lowdown on the premium Covid treatment drug, Remdesivir
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Lucknow , Uttar-pradesh , India , Mumbai , Maharashtra , Bengaluru , Karnataka , Krishna-kumar , Vikas-dandekar , Vatsala-gaur , லக்னோ